Journal of Digital Convergence (디지털융복합연구)

The Society of Digital Policy and Management (한국디지털정책학회)
권호 표지
DOI QR코드

DOI QR Code

Interregional Variant Factor Analysis of Hypertension Treatment Rate in COVID-19

코로나19에서 고혈압 치료율의 지역 간 변이요인 분석

  • Park, Jong-Ho (Division of Health Administration, Gwangju University) ;
  • Kim, Ji-Hye (Dept. of Health Administration, Jinju Health College)
  • 박종호 (광주대학교 보건행정학부) ;
  • 김지혜 (진주보건대학교 보건행정과)
  • Received : 2022.02.18
  • Accepted : 2022.04.20
  • Published : 2022.04.28
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study is to analyze regional variation factors of hypertension treatment rate in COVID-19 based on the analysis results based on ecological methodology. To this end, data suitable for ecological analysis were collected from the Korea Centers for Disease Control and Prevention's regional health statistics, local government COVID-19 confirmed cases, National Health Insurance Corporation, Health Insurance Review and Assessment Service's welfare statistics, and Korea Transport Institute's traffic access index. Descriptive statistics and correlation analysis were conducted using SPSS Statistics 23 for regional variation and related factors in hypertension treatment rate, and geographical weighted regression analysis was conducted using Arc GIS for regional variation factors. As a result of the study, the overall explanatory power of the calculated geo-weighted regression model was 27.6%, distributed from 23.1% to 33.4% by region. As factors affecting the treatment rate of hypertension, the higher the rate of basic living security medical benefits, diabetes treatment rate, and health institutions per 100,000 population, the higher the rate of hypertension treatment, the lower the number of COVID-19 confirmed patients, the lower the rate of physical activity, and the alcohol consumption. Percentage of alcohol consumption decreased due to COVID-19 pandemic. It was analyzed that the lower the ratio, the higher the treatment rate for hypertension. Based on these results, the analysis of regional variables in the treatment rate of hypertension in COVID-19 can be expected to be effective in managing the treatment rate of hypertension, and furthermore, it is expected to be used to establish community-centered health promotion policies.

본 연구의 목적은 코로나19에서 고혈압 치료율의 지역 간 변이요인을 분석하는 것이다. 이를 위해 생태학적 분석에 적합한 데이터를 2020년 질병관리청 지역건강통계, 각 지자체 코로나19 확진자 현황 자료, 국민건강보험공단, 건강보험심사평가원의 건강보험통계, 한국사회보장정보원의 복지통계, 한국교통연구원의 교통접근성 지표 자료를 수집하였다. 고혈압 치료율의 지역 간 변이와 관련 요인을 SPSS Statistics 23을 활용하여 기술통계, 상관분석을 실시하였으며, 지역 간 변이 요인을 Arc GIS를 이용하여 지리적 가중회귀분석을 실시하였다. 연구결과로 지리적 가중회귀모형의 전반적인 설명력은 27.6%였으며, 지역별로는 23.1%에서 33.4%까지 분포하는 것으로 나타났고, 고혈압 치료율에 영향을 미치는 요인으로 기초생활보장 의료급여 수급자 비율, 당뇨병 치료율, 인구10만 명당 보건기관 수가 높을수록 고혈압 치료율이 높았으며, 코로나19 확진자수, 코로나19 유행으로 감소된 신체활동 비율, 코로나19 유행으로 감소된 음주 비율이 낮을수록 고혈압 치료율이 높은 것으로 분석되었다. 이러한 결과를 기반으로 코로나19에서 고혈압 치료율의 지역 간 변이요인 분석은 효과적인 고혈압 치료율 관리 사업을 기대할 수 있을 것이며, 더 나아가 지역사회 중심의 건강증진 정책 수립에 활용될 것으로 기대된다.

Keywords

Acknowledgement

This Study was conducted by research funds from Gwangju University in 2022.

References

  1. Korea Disease Control and Prevention Agency, (2020). 2020 National Health Statistics. https://knhanes.kdca.go.kr/
  2. E. S. Min, M. H. Hur. (2012). Predictors of Compliance in Hypertensive Patients. J Korean Acad Fundam Nurs, 19(4), 474-482. https://doi.org/10.7739/jkafn.2012.19.4.474
  3. National Statistical Office, (2020). 2019 Cause of Death Statistics, http://kostat.go.kr
  4. Information on the prevention and management of hypertension for me and my family (2016). Korean Academy of Medical Sciences.
  5. M Mobula, J Heller el al.,(2020). Protecting the vulnerable during COVID-19: Treating andpreventing chronic disease disparities, Gates open research, 4, 125. DOI : 10.12688/gatesopenres.13181.1
  6. World Health Organization. (2020a). Transmission of SARS-CoV-2: implications forinfection prevention precautions. Scientific brief. World health Organiztion. DOI : WHO/2019-nCoV/Sci_Brief/Transmission_modes/2020.3
  7. S Lail, N. W. Ruktanonchai, L Zhou, O Prosper, W Luo, R Floyd, A Tatem et al., (2020). Effect of non-pharmaceutical interventions to containCOVID-19 in China, Nature, 585(7825), 410-413. DOI : 10.1038/s41586-020-2293-x
  8. N. G. Davies, A. J. Kucharski, R. M. Eggo, A Gimma, W. J. Edmunds et al., (2020). ffects of non-pharmaceutical interventions onCOVID-19 cases, deaths, and demand for hospital services in the UK: amodelling study, The Lancet Public Health, 5(7), 375-385. DOI : 10.1016/S2468-2667(20)30133-X
  9. A Khera, J Baum, J Gluckman, M Gulati et al., (2020). Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology" Americal Journal of Preventive Cardiology, 1. DOI : 10.1016/j.ajpc.2020.100009
  10. S Garcia, M Albaghdadi, M Meraj et al., (2020). Reduction in ST-segment elevation cardiaccatheterization laboratory activations in the United States during COVID-19pandemic, Journal of the Americcal College of Cardiology, 75(22), 2871-2872. DOI : 10.1016/j.jacc.2020.04.011
  11. O Rodriguez- Leor, B Cid- Alvarez, S ojeda et el., (2020). Impacto de la pandemia de COVID-19sobre la actividad asistencial en cardiologia intervencionista en Espana, REC Interv Cardiol, 2, 82-89.
  12. S Ahn, S Kim, K Koh, (2020). Changes in Healthcare Utilization, Spending, and Perceived Health during COVID-19: A Longitudinal Study from Singapore. Spending, and Perceived Health during COVID-19: A Longitudinal Study from Singapore S. IZA Discussion Pap, 13715. DOI : 10.2139/ssrn.3695416
  13. J. Y Kim, (2020). Changes in health insurance medical expenses before and after COVID-19 and implications, National Assembly Budget Office, NABO FOCUS, 26.
  14. Public opinion: Post-Corona era, changes in our medical care and the future Weekly Report of Korean Research (2020). Hankook Research & National Health Insurance Servicce, 86(1).
  15. K. J Yoon, (2020). Changes and Tasks in Korea's Healthcare System in Times of the Covid-19 Pandemic, Health and Welfare Forum, 290, 34-49.
  16. I. S. Sohn, (2020). Summary of the Relationship between COVID-19 and Cardiovascular Disease, CDC, 13(36), 2686-2693. http://www.cdc.go.kr
  17. M Vaduganathan, O Vardeny, T Michel, JJV McMurray, MA Pfeffer, SD Solomon, (2020). Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 382(17), 1653-1659. DOI : 10.1056/NEJMsr2005760
  18. H. S. Seok, S. H. Kang, (2013). A Study on The Regional Variation Factor of hypertension Prevalence, Health and Social Welfare Review, 33(3), 210-236. DOI : 10.15709/hswr.2013.33.3.210
  19. J. Y Kim, (2020). Changes in health insurance medical expenses before and after COVID-19 and implications, National Assembly Budget Office, NABO FOCUS, 26. https://www.nabo.go.kr/
  20. M. K. Jang, J. Y. Choi, H. J. Lee el al,. (2021). Pediatric Emergency Department Utilizationand Coronavirus Diseasein Daegu, Korea. Journal of Korean medical science, 36(1), 1-12. DOI : https://doi.org/10.3346/jkms.2021.36.e11
  21. S. H Kang, J. H Park, J. H Kim, (2021). Development of a Simulation Model for Managing High-Risk Drinking Rates to Improve the Health Level of Local Communities, Journal of the Korea Academia-Industrial cooperation Society, 22(9), 575-587. DOI : 10.5762/KAIS.2021.22.9.575
  22. I. S Park, (2016). An analysis on metropolitan concentration factors of health care utilization in Local Cancer Patients Using GWR, Journal of Community Welfare 0(56), 29-56. DOI : 10.15300/jcw.2016.56.1.29
  23. K Akerblom, A Reunanen, (1985). The epidemiology of insulin- dependent diabetes mellitus (IDDM) in finland and in northern europe, Diabetes Care, 8, 10-16. DOI : 10.2337/DIACARE.8.1.S10
  24. R Gupta, A Misra, (2007). Review: Type 2 diabetes in india: Regional disparities. The British Journal of Diabetes & Vascular Disease, Crossref, 7(1), 12-16. DOI : 10.1177/14746514070070010301
  25. D. H Kim, (2010). Analysis of Small Area Variation of Health Behaviorusing 2008 Community Health Survey in Korea, Centers for Disease Control and Prevention Policy Report, Korea, 48-55.
  26. E Barker, A Kirtland, W Gregg et al., (2011). Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt, American Journal of Preventive Medicine, 40(4), 434-443. DOI : 10.1016/j.amepre.2010.12.019
  27. S Schipf, A Werner, T Tamayo et al., (2012). Regional differences in the prevalence of known type 2 diabetes mellitus in 45-74 years old individuals: Results from six population-based studies in germany (DIAB-CORE consortium), Diabetic Medicine : A Journal of the British Diabetic Association, 29(7), 88-95. DOI : /10.1111/j.1464-5491.2012.03578.x
  28. H. S Seok, S. H Kang, (2013). Study on the Regional Variaation Factor of Hypertension Prevalence, Health and Social Welfare Review, 33(3), 201-236. DOI : 10.15709/hswr.2013.33.3.210
  29. D. G Jo, (2009). GIS and Geographically Weighted Regression in the Survey Research of Small Areas, Survey Research, 10(3), 1-19. DOI : 10.15300/jcw.2016.56.1.29
  30. Korea Disease Control and Prevention Agency, (2020). Guidelines for COVID-19 Prevention1, http://ncov.mohw.go.kr/baroView4.do?brdId=4&brdGubun=44
  31. Korea Disease Control and Prevention Agency, (2020). 2020 Regional Health Statistics at a Glance, Community Health Survey, http://chs.kdca.go.kr
  32. B. R Sim, (2021). An Empirical Analysis on Geographic Variations in the Prevalence of Diabetes, PhD dissertation, Dept. of Health Administration The Graduate School Yonsei University, 1-100.
  33. H. H Kluge, K. Wickramasinghe, H. L Mendes, R Peters, D. H Kontsevaya, J. A., & Breda, (2020). Prevention and control ofnon-communicable diseases in the COVID-19 response, The Lancet, 395(10238), 1678-1680. DOI : 10.1016/S0140-6736(20)31067-9
  34. P Katulanda, H. A Dissanayake, I Ranathunga, V Ratnasamy, P. S Wijewickrama, N Yogendranathan, & D. R Matthews, (2020). Prevention andmanagement of COVID-19 among patients with diabetes: an appraisal of theliterature. Diabetologia, 63(8), 1440-1452. DOI : 10.1007/s00125-020-05164-x
  35. J Kim, D. W Kim, K. I Kim, H. B Kim, J. H Lee, Y. G Byeon, K. H Cheong, H. K., & Korean Society of Hypertension, (2020). Compliance ofAntihypertensive Medication and Risk of Coronavirus Disease 2019: a CohortStudy Using Big Data from the Korean National Health Insurance Service. Journal of Korean medical science, 35(25), e232. DOI : 10.3346/jkms.2020.35.e232